Literature DB >> 19001346

Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies.

Rachel Wong, David Cunningham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001346     DOI: 10.1200/JCO.2008.19.5024

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  29 in total

1.  Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients.

Authors:  Zhe-Zhen Li; Long Bai; Feng Wang; Zi-Chen Zhang; Fang Wang; Zhao-Lei Zeng; Jun-Bo Zeng; Dong-Sheng Zhang; Feng-Hua Wang; Zhi-Qiang Wang; Yu-Hong Li; Jian-Yong Shao; Rui-Hua Xu
Journal:  Med Oncol       Date:  2016-06-06       Impact factor: 3.064

2.  KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary colorectal cancers diagnostic and therapeutic implications.

Authors:  Katharina Balschun; Jochen Haag; Ann-Kathrin Wenke; Witigo von Schönfels; Nicolas T Schwarz; Christoph Röcken
Journal:  J Mol Diagn       Date:  2011-05-04       Impact factor: 5.568

3.  Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer.

Authors:  Alfonso De Stefano; Chiara Carlomagno
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 4.  Multidisciplinary approach of colorectal liver metastases.

Authors:  I Juez; C Rubio; J Figueras
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

Review 5.  Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.

Authors:  Cristiana Lo Nigro; Vincenzo Ricci; Daniela Vivenza; Cristina Granetto; Teresa Fabozzi; Emanuela Miraglio; Marco C Merlano
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

6.  The epidermal growth factor receptor conundrum.

Authors:  Jason A Wilken; Andre T Baron; Nita J Maihle
Journal:  Cancer       Date:  2010-12-14       Impact factor: 6.860

Review 7.  Molecular origins of cancer: Molecular basis of colorectal cancer.

Authors:  Sanford D Markowitz; Monica M Bertagnolli
Journal:  N Engl J Med       Date:  2009-12-17       Impact factor: 91.245

8.  KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.

Authors:  Paloma Cejas; Miriam López-Gómez; Cristina Aguayo; Rosario Madero; Javier de Castro Carpeño; Cristóbal Belda-Iniesta; Jorge Barriuso; Víctor Moreno García; Javier Larrauri; Rocío López; Enrique Casado; Manuel Gonzalez-Barón; Jaime Feliu
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

9.  KRAS mutations and subtyping in colorectal cancer in Jordanian patients.

Authors:  Wafa M Elbjeirami; Maher A Sughayer
Journal:  Oncol Lett       Date:  2012-07-04       Impact factor: 2.967

10.  Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases.

Authors:  Georgios Karagkounis; Michael S Torbenson; Hubert D Daniel; Nilofer S Azad; Luis A Diaz; Ross C Donehower; Kenzo Hirose; Nita Ahuja; Timothy M Pawlik; Michael A Choti
Journal:  Cancer       Date:  2013-09-19       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.